For instance, OR2B6 overexpression has been reported in breast cancer, and OR51E1 has been found to be elevated in advanced prostate cancer and other solid tumors, consistent with our findings [18,26,30,31,32]. Here, OR2B6 is linked to prostate carcinoma.